Online registrations will be opening soon
Online registrations will be opening soon
Medical Surgeon (Clinical Pathology,
General Medicine (Family Doctors), Haematology, Internal Medicine, Medical Genetics, Nuclear Medicine, Oncology, Pathological Anatomy, Pharmacology and Clinical Toxicology, Radiology, Radiotherapy),
Biologist, Pharmacist,
Chemist (Analytical Chemistry),
Physicist (Health Physics),
Veterinary
Hotel NH Venezia Laguna Palace
Viale Ancona, 2
30172 – Venezia
Italy
English
Simultaneous translation
will not be provided
Abstract guidelines can be downloaded here.
Abstracts must be sent by July 15, 2022 and must focus on the following topics:
Abstract submission opens on June 1st, 2022.
The SIC Annual Meeting is the focal point of the Italian cancer research community, where preclinical and clinical scientists gather together to share the latest advances in cancer research and cure. In the last few years, we have witnessed, as never before, the rapid translation of preclinical research into clinical application.
The program of the 62nd SIC Annual Meeting, entitled “The exciting path from preclinical research to clinical application” will focus on the challenges posed by the rapid development of the precision medicine approaches, including the need for a better understanding of tumor heterogeneity and drug resistance mechanisms, and the ongoing efforts necessary for a better patients stratification for radio-, chemo-, targeted- and immune- therapies, to increase the number of patients with durable clinical responses.
The meeting will be of interest for both preclinical and clinical researchers, working in different areas of cancer research.
In light of this broad attendance, we have designed scientific sessions in which most compelling topics will be discussed from different perspectives.
Participants to this CME event will thus have the opportunity to gain new knowledge and discuss several aspects of cancer research, including:
How particular targeted agents, radiotherapy and immunotherapies have been selected for their use, in patients with advanced cancer.
How to integrate the use of molecular profiling to select the most appropriate treatment for each patient.
How to evaluate the role of new emerging drugs and which is the biology underlying their efficacy.
Which are the main mechanisms of drug resistance and how combination therapies may increase treatment response or durability.
For the first time in Venice, SIC this year will also hold an open session dedicated to survivors, patients, care givers and all stakeholders involved in the cancer care. In an interactive round table, it will be discussed why and how research can impact on cancer prevention, treatment and patients’ quality of life.
RESIDENTIAL Before September 16, 2022 | RESIDENTIAL After September 16, 2022 | VIRTUAL Before September 16, 2022 | VIRTUAL After September 16, 2022 |
|
---|---|---|---|---|
SIC member | 420,00 € | 500,00 € | 150,00 € | 200,00 € |
Young SIC member | 280,00 € | 330,00 € | 120,00 € | 150,00 € |
Non member | 500,00 € | 600,00 € | 200,00 € | 250,00 € |
Young non member | 380,00 € | 400,00 € | 150,00 € | 200,00 € |
Registration fees include:
RESIDENTIAL Before September 16, 2022 | RESIDENTIAL After September 16, 2022 |
|
---|---|---|
SIC member | 420,00 € | 500,00 € |
Young SIC member | 280,00 € | 330,00 € |
Non member | 500,00 € | 600,00 € |
Young non member | 380,00 € | 400,00 € |
VIRTUAL Before September 16, 2022 | VIRTUAL After September 16, 2022 |
|
---|---|---|
SIC member | 150,00 € | 200,00 € |
Young SIC member | 120,00 € | 150,00 € |
Non member | 200,00 € | 250,00 € |
Young non member | 150,00 € | 200,00 € |
Registration fees include:
Gustavo Baldassarre
Head of the Molecular Oncology Unit,
Centro di Riferimento Oncologico di Aviano (CRO), IRCCS
National Cancer Institute (NCI), Aviano (PN), Italy
Fabio Puglisi
Head of the Department of Medical Oncology,
Centro di Riferimento Oncologico di Aviano (CRO), IRCCS
National Cancer Institute (NCI), Aviano (PN), Italy
Professor of Medical Oncology,
Head of the School of Medical Oncology,
Department of Medicine, University of Udine, Italy.
Barbara Belletti
IRCCS Centro di Riferimento Oncologico di Aviano,
Aviano (PN)
Vincenzo Canzonieri
IRCCS Centro di Riferimento Oncologico di Aviano,
Aviano (PN)
Saverio Cinieri
“Sen. Antonio Perrino Hospital”, Brindisi – AIOM President
Pierfranco Conte
IRCCS Istituto Oncologico Veneto – University di Padova
Giannino Del Sal
University of Trieste – IFOM, Milan
Silvia Franceschi
IRCCS Centro di Riferimento Oncologico di Aviano,
Aviano (PN)
Valter Gattei
IRCCS Centro di Riferimento Oncologico di Aviano,
Aviano (PN)
Valentina Guarneri
IRCCS Istituto Oncologico Veneto – University di Padova
Stefano Indraccolo
IRCCS Istituto Oncologico Veneto – University di Padova
Roberta Maestro
IRCCS Centro di Riferimento Oncologico di Aviano, Aviano (PN)
Michele Milella
University of Verona
Paolo Morandi
“Dell’Angelo” Hospital, Mestre (VE)
Flavio Rizzolio
University Ca’ Foscari, Venice
Aldo Scarpa
University of Verona
Agostino Steffan
IRCCS Centro di Riferimento Oncologico di Aviano, Aviano (PN)
Gianluca Tell
University of Udine
Nicola Normanno
National Cancer Institute, G. Pascale, Napoli
Maurizio D’Incalci
Humanitas Research Hospital and Humanitas University, Milano
Gabriella Sozzi
Fondazione IRCCS National Cancer Institute, Milano
Ilaria Guerriero
Biogem Institute for Genetic Research G. Salvatore, Ariano Irpino (AV)
Erica Torchiaro
Candiolo Cancer Institute FPO-IRCCS, Torino
Paola Allavena
Humanitas Research Hospital, Milano
Gustavo Baldassarre
IRCCS Centro di Riferimento Oncologico di Aviano, Aviano (PN)
Fabrizio Bianchi
IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo (FG)
Giovanni Blandino
Regina Elena National Cancer Institute, Roma
Antonino Bruno
IRCCS MultiMedica, Milano
Paola Chiarugi
University of Firenze
Federica Di Nicolantonio
University of Torino and Candiolo Cancer Institute FPO-IRCCS
A technical, pharmaceutical and publication exhibition will be held in the Congress Venue. For any information, please contact the Organizing Secretariat.
The 62th annual Meeting of the Italian Cancer Sociaty will take place in
Hotel NH Venezia Laguna Palace
Viale Ancona, 2
30172 – Venezia
Italy
Venezia, Novembre 16th 2022
La SIC incontra la Società Civile
L’oncologia di precisione:
una realtà dalla prevenzione dalla terapia